Dennis Sanche

Ichor Life Sciences is a longevity biotechnology company and end-to-end contract research organization. It is the first and oldest longevity-focused venture studio and home to the oldest industry PhD program for drug discovery for longevity. Within its venture studio, the Ichor portfolio companies have four preclinical candidates focused on age-related diseases. As a CRO, Ichor helps biotechnology and pharmaceutical companies solve their most difficult challenges at every stage of research and development—from ideation to FDA approval—using a personalized approach that puts relationships and science first. Ichor offers: Protein services Pharmacology and discovery services Consulting services Clinical trial site identification Site qualification Recruitment Specialty consulting Protocol design With its breadth of expertise as a CRO and drug developer, Ichor is helping clients rapidly advance their research and development programs while pioneering the longevity and anti-aging biotechnology industry.

Aging has been called “the emperor of all maladies.” Turn Bio’s goal is to address multiple aging-related indications using a single powerful reprogramming therapy that turns old cells young again, aiding in the rejuvenation of an aged human body. In 2013, a paper in Cell (The hallmarks of aging, López-Otin et al.,) proposed nine key “Hallmarks of Aging” that are causes of the general phenotype we refer to as “aging.” Our team recognized that it would be necessary to “turn back the clock” on each of these hallmarks and so set out to develop the technology to do just that. The task was achieved by a using a proprietary cocktail of transiently-administered rejuvenation factors that have now been shown to reverse eight of the nine hallmarks. Join us as we embark on the task to "turn back time."​

Repair Biotechnologies is a preclinical biotechnology company focused on developing drugs for cholesterol and aging-related diseases. Our first-in-class Cholesterol Degrading Platform (CDP) technology is aimed at reversing atherosclerosis, familial hypercholesterolemias, and other conditions in which excess or modified cholesterol drives pathology.

Nine is an intuitive banking platform for one stop personalized shopping. Shop more, smarter, secure, personal

Ichor Life Sciences is a longevity biotechnology company and end-to-end contract research organization. It is the first and oldest longevity-focused venture studio and home to the oldest industry PhD program for drug discovery for longevity. Within its venture studio, the Ichor portfolio companies have four preclinical candidates focused on age-related diseases. As a CRO, Ichor helps biotechnology and pharmaceutical companies solve their most difficult challenges at every stage of research and development—from ideation to FDA approval—using a personalized approach that puts relationships and science first. Ichor offers: Protein services Pharmacology and discovery services Consulting services Clinical trial site identification Site qualification Recruitment Specialty consulting Protocol design With its breadth of expertise as a CRO and drug developer, Ichor is helping clients rapidly advance their research and development programs while pioneering the longevity and anti-aging biotechnology industry.

Aging has been called “the emperor of all maladies.” Turn Bio’s goal is to address multiple aging-related indications using a single powerful reprogramming therapy that turns old cells young again, aiding in the rejuvenation of an aged human body. In 2013, a paper in Cell (The hallmarks of aging, López-Otin et al.,) proposed nine key “Hallmarks of Aging” that are causes of the general phenotype we refer to as “aging.” Our team recognized that it would be necessary to “turn back the clock” on each of these hallmarks and so set out to develop the technology to do just that. The task was achieved by a using a proprietary cocktail of transiently-administered rejuvenation factors that have now been shown to reverse eight of the nine hallmarks. Join us as we embark on the task to "turn back time."​

Repair Biotechnologies is a preclinical biotechnology company focused on developing drugs for cholesterol and aging-related diseases. Our first-in-class Cholesterol Degrading Platform (CDP) technology is aimed at reversing atherosclerosis, familial hypercholesterolemias, and other conditions in which excess or modified cholesterol drives pathology.